Narcolepsy With or Without Cataplexy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Narcolepsy With or Without Cataplexy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (8 shown)

Not Yet RecruitingPhase 3

NCT07540364

A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy

The primary objective of this study is to evaluate the effect of Samelisant on excessive daytime sleepiness (EDS) after 12 weeks of treatment. In addition, the…

Location not specified240 participantsStarted 2026-06-19

Treatment: Samelisant, Placebo

CompletedPhase 3

NCT02611687

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Follow…

The purpose of this multicenter double blind study is to assess efficacy and safety of Pitolisant versus placebo in paediatric Narcoleptic patients with or with…

Finland, France, Italy110 participantsStarted 2016-06-06

Treatment: pitolisant, Placebo

Narcolepsy With or Without Cataplexy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (8 shown)

A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Follow…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (8 shown)

A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Follow…

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepi…

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Flumazenil for the Treatment of Primary Hypersomnia

Single-dose Safety Study of APD916 in Healthy Volunteers